• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.

作者信息

Montorsi Francesco, Salonia Andrea, Briganti Alberto

机构信息

Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

Eur Urol. 2020 Nov;78(5):e192. doi: 10.1016/j.eururo.2020.07.031. Epub 2020 Aug 13.

DOI:10.1016/j.eururo.2020.07.031
PMID:32800728
Abstract
摘要

相似文献

1
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Nov;78(5):e192. doi: 10.1016/j.eururo.2020.07.031. Epub 2020 Aug 13.
2
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e114-e115. doi: 10.1016/j.eururo.2020.05.034. Epub 2020 Jun 10.
3
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e118-e119. doi: 10.1016/j.eururo.2020.06.057. Epub 2020 Jul 15.
4
Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e116-e117. doi: 10.1016/j.eururo.2020.05.036. Epub 2020 Jun 11.
5
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e120-e121. doi: 10.1016/j.eururo.2020.07.005. Epub 2020 Jul 16.
6
Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.对弗朗切斯科·蒙托西、安德里亚·萨洛尼亚和阿尔贝托·布里甘蒂致编辑的信的回复，信的主题为：丽莎·莫里、马库斯·G·坎伯巴奇、托马斯·范登布罗克等人。高危局限性和局部进展性前列腺癌主要治疗方法的获益与风险：一项国际多学科系统评价。《欧洲泌尿外科杂志》2020年；77卷：614 - 27页。
Eur Urol. 2020 Nov;78(5):e193-e194. doi: 10.1016/j.eururo.2020.07.041. Epub 2020 Aug 21.
7
Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e15. doi: 10.1016/j.eururo.2019.03.028. Epub 2019 Apr 1.
8
Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复周雪亮和韩新伟致编辑的信，内容涉及：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等人。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e16. doi: 10.1016/j.eururo.2019.03.027. Epub 2019 Apr 6.
9
Re: Nicola Fossati, Peter-Paul M. Willemse, Thomas Van den Broeck, et al. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. Eur Urol 2017;72:84-109: Lymphadenectomy and Radical Prostatectomy: Science or Pseudoscience?回复：尼古拉·福萨蒂、彼得 - 保罗·M·威廉姆斯、托马斯·范登布罗克等。前列腺癌根治性前列腺切除术中不同范围淋巴结清扫的益处与危害：一项系统评价。《欧洲泌尿外科杂志》2017年；72卷：84 - 109页：淋巴结清扫与根治性前列腺切除术：科学还是伪科学？
Eur Urol. 2018 Mar;73(3):e75-e76. doi: 10.1016/j.eururo.2017.05.020. Epub 2017 Jun 2.
10
Re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019;76:871.回复：关于玛丽亚·基娅拉·西格诺尔菲，贝尔纳多·罗科关于欧洲泌尿外科学会（EAU）指南：2019年前列腺癌的至理名言。莫泰 N、范登伯格 RCN、布riers E 等。https://uroweb.org/guideline/prostate-Cancer/。《欧洲泌尿外科杂志》2019年；76:871。
Eur Urol. 2020 May;77(5):e122-e127. doi: 10.1016/j.eururo.2020.02.005. Epub 2020 Feb 20.